PropofolThird Party Manufacturing in India

Propofol works by positive allosteric modulation of the GABA-A (gamma-aminobutyric acid type A) receptor. It binds to the receptor to enhance the inhibitory neurotransmitter effects of GABA, prolonging the opening time of the chloride channel. This results in cellular hyperpolarization and rapid, reversible inhibition of neuronal transmission in the central nervous system, leading to the fast induction of hypnosis, sedation, and general anesthesia with minimal excitatory symptoms.

Therapeutic Uses

Propofol is indicated for the induction and maintenance of sedation and general anesthesia:

• General Anesthesia Induction: Rapidly induces hypnosis in patients undergoing surgical procedures.
• Anesthesia Maintenance: Used as a continuous infusion to maintain sedation during major surgery.
• ICU Sedation: Indicated for sedating mechanically ventilated adult patients in intensive care units.
• Procedural Sedation: Provides short-term sedation for diagnostic or minor surgical procedures.

Why Manufacturers Choose Propofol

Propofol is the most widely utilized intravenous anesthetic in hospitals globally, ensuring massive and steady clinical demand. Formulating propofol as a sterile lipid emulsion (1% or 2% strengths) requires highly advanced sterilization and micro-homogenization technologies to prevent lipid separation and microbiological growth.

Because of these high formulation barriers, competition in the B2B contract manufacturing market is relatively low. Partnering with a WHO-GMP certified facility for Propofol third party manufacturing in India allows distributors to supply premium-grade, highly stable emulsions to hospital networks, securing consistent, high-value hospital sales and export volume.